FDA Walks Back Claim of Dramatic Benefit From Blood Plasma Covid Therapy

66

The head of the U.S. Food and Drug Administration walked back his claim that an experimental therapy had provided a dramatic benefit to Covid-19 patients, a rare reversal for an agency that has prided itself on rock-solid science and public…